Molecular genetic analysis of p53 intraturnoral heterogeneity in human astrocytic brain tumors

被引:25
|
作者
Ren, Zhi-Ping
Olofsson, Tommie
Qu, Mingqi
Hesselager, Goran
Soussi, Thierry
Kalimo, Hannu
Smits, Anja [1 ]
Nister, Monica
机构
[1] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Univ Uppsala Hosp, Dept Genet & Pathol, S-75185 Uppsala, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden
[4] Sichuan Univ, W China Hosp, Dept Neurosurg, Sichuan, Peoples R China
[5] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland
关键词
clonality; glioma; heterogeneity; microdissection; mutation; p53;
D O I
10.1097/nen.0b013e318156bc05
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We investigated genetic heterogeneity of astrocytic gliomas using p53 gene mutations as a marker. Different parts of morphologically heterogeneous astrocytic gliomas were micro-dissected, and direct DNA sequencing of p53 gene exons 5 through 8 was performed. Thirty-five glioma samples and tumor-adjacent normal-appearing brain tissue from I I patients were analyzed. Sixteen different p53 gene mutations were found in 7 patients. We found that some tumors were devoid of p53 gene mutations, whereas other tumors carried I or often several (up to 3) different mutations. The mutations were present in grade II, III, and IV astrocytic glioma areas. Both severe functionally dead mutants and mutants with remaining transcriptional activity could be observed in the same tumor. We observed that morphologically different parts of a glioma could carry different or similar mutations in the p53 gene and could be either associated or not associated with the locus of heterozygosity at the mutant site. Coexistence of p53 gene mutations and the locus of heterozygosity was common, at least in astrocytomas grade III and in glioblastomas, and also occurred in astrocytoma grade 11 areas. These results support the notion that intratumoral heterogeneity in brain tumors originates from different molecular defects. Our results are of importance for a further understanding of the molecular mechanisms behind failure to treat glioma patients.
引用
收藏
页码:944 / 954
页数:11
相关论文
共 50 条
  • [41] p53 expression in human gestational trophoblastic tumors
    Li, FS
    Shao, ZT
    Cang, WM
    Qian, N
    CHINESE MEDICAL JOURNAL, 1998, 111 (04) : 379 - 380
  • [42] P53 MUTATIONS IN HUMAN LUNG-TUMORS
    MILLER, CW
    SIMON, K
    ASLO, A
    KOK, K
    YOKOTA, J
    BUYS, CHCM
    TERADA, M
    KOEFFLER, HP
    CANCER RESEARCH, 1992, 52 (07) : 1695 - 1698
  • [43] p53 expression in human gestational trophoblastic tumors
    李凤山
    邵振堂
    仓为民
    钱宁
    ChineseMedicalJournal, 1998, (04)
  • [44] SIGNIFICANCE OF P53 IN HUMAN THYROID-TUMORS
    SIMON, D
    GORETZKI, PE
    GORELEV, V
    EBLING, B
    REISHAUS, E
    LYONS, J
    HAUBRUCK, H
    ROHER, HD
    WORLD JOURNAL OF SURGERY, 1994, 18 (04) : 535 - 541
  • [45] P53 GENE MUTATION IN HUMAN SOLID TUMORS
    THEILLET, C
    BULLETIN DU CANCER, 1993, 80 (08) : 693 - 696
  • [46] p53 expression in human gestational trophoblastic tumors
    李凤山
    邵振堂
    仓为民
    钱宁
    中华医学杂志(英文版), 1998, (04)
  • [47] P53 MUTATIONS IN HUMAN EPITHELIAL SKIN TUMORS
    MOLES, JP
    MAZARS, R
    GUILLOT, B
    GUILHOU, JJ
    THEILLET, C
    BASSETSEGUIN, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 514 - 514
  • [48] Distinct pattern of p53 phosphorylation in human tumors
    Toshinari Minamoto
    Thomas Buschmann
    Hasem Habelhah
    Ekaterina Matusevich
    Hidetoshi Tahara
    Anne-Lise Boerresen-Dale
    Curtis Harris
    David Sidransky
    Ze'ev Ronai
    Oncogene, 2001, 20 : 3341 - 3347
  • [49] IMMUNOCHEMICAL ANALYSIS OF THE P53 ONCOPROTEIN IN MATCHED PRIMARY AND METASTATIC HUMAN TUMORS
    BARTKOVA, J
    BARTEK, J
    VOJTESEK, B
    LUKAS, J
    REJTHAR, A
    KOVARIK, J
    MILLIS, RR
    LANE, DP
    BARNES, DM
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 881 - 886
  • [50] Genetic analysis of p53 nuclear importation
    Li, Q.
    Falsey, R. R.
    Gaitonde, S.
    Sotello, V.
    Kislin, K.
    Martinez, J. D.
    ONCOGENE, 2007, 26 (57) : 7885 - 7893